Expanding Indications for Surgical Resection in Hepatocellular Carcinoma: What is the Evidence?

Surg Oncol Clin N Am. 2024 Jan;33(1):99-109. doi: 10.1016/j.soc.2023.07.004. Epub 2023 Aug 29.

Abstract

Hepatic resection is one of the mainstays of curative therapy for hepatocellular carcinoma (HCC). The appropriate selection of resectable candidates requires careful consideration of a multitude of factors including tumor burden (size and number of nodules, presence of vascular involvement, extrahepatic spread), patient factors (performance status, underlying liver function), and availability of other therapies (access to transplantation, interventional procedures, immunotherapies). Historically, hepatic resection for HCC has been reserved for patients with solitary tumors without vascular invasion. However, in well-selected patients HCC tumors multifocal in nature or with vascular invasion should be considered for hepatic resection.

Keywords: Hepatic resection; Hepatocellular carcinoma; Portal vein tumor thrombosis; Surgical resection.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Carcinoma, Hepatocellular* / surgery
  • Hepatectomy / methods
  • Humans
  • Liver Neoplasms* / pathology
  • Liver Neoplasms* / surgery